Recent findings in Nature Medicine (Nihart, Garcia, El Hayek et al., 2025) confirm a grim reality: microplastics have breached the human blood–brain barrier (BBB). Over an eight-year span (2016–2024), concentrations in decedent brain samples rose by about 50%. Far from a trivial pollutant, plastic is seeping into our most precious organ, threatening cognitive function, immune responses, and possibly even long-term neurological stability.
“The microbes will handle it.”
Yet, rather than ending the avalanche of plastic production, industry spokespeople continue spinning fantasies of a “microbial solution.” They point to enzyme-based or bacterial “breakthroughs” that supposedly degrade plastic. This techno-utopian narrative distracts us from the brutal fact: unless we slash plastic at the source, the toxic cascade, now penetrating human brains, will only intensify.
The blood–brain barrier is meant to protect the central nervous system from foreign invaders. But in mice, nanoplastics reached the brain within two hours of ingestion, and simulations suggest that the particle’s biomolecular corona shapes how easily it crosses (Kopatz et al., 2023).
The Nature Medicine study (Nihart et al., 2025) used pyrolysis gas chromatography–mass spectrometry and electron microscopy on liver, kidney and brain tissue from 20 to 28 decedents per time point. It found brain particles that were largely 100–200 nm shards and flakes. Given that plastic often contains harmful additives such as phthalates, bisphenols, and flame retardants, its infiltration of neuronal tissue is nothing short of an environmental and public health calamity.
Why the microbes won’t arrive in time
Much of the hype focuses on Ideonella sakaiensis or engineered enzyme systems that can break down polyethylene terephthalate (PET). Since Yoshida et al. (2016) first reported a bacterium capable of degrading PET, subsequent studies have attempted to boost enzyme efficiency (Taniguchi et al., 2019; Knott et al., 2020; Palm et al., 2019; Tournier et al., 2023). Others have explored various PET hydrolases with an eye toward industrial recycling (Kawai, Kawabata, & Oda, 2020; Wei & Zimmermann, 2017).
The reality is ugly. Even in optimized lab conditions, breakdown is slow, light-years behind the rate of new plastic production. It’s partial, not total: the decomposition of PET can leave micro- and nanoplastic fragments, accelerating the release of toxic additives. And these enzymes often demand specific pH, temperature, or cofactors absent in landfills, oceans, or everyday environments (Knott et al., 2020).
Corporate PR teams latch onto every new enzyme tweak, promising we can keep churning out plastic guilt-free because “the microbes will handle it.” This is a stall tactic that buys time to delay strict regulation and taxes on virgin polymer.
Some optimists insist that if we flood the world with plastic, bacteria will “coevolve” to digest it. They reference evolutionary biology and even cite Margulis’s (1981) endosymbiotic theory, suggesting plastic-chomping microbes might become akin to mitochondria. This is delusion. The timescale for such beneficial symbiosis spans millennia, whereas microplastic infiltration of human tissues has soared in mere decades.
These “optimistic” claims ignore the immediate hazards. Phthalates, bisphenols, and other additives often leach out faster than microbes can neutralize them. And the longer we stall, the more plastic seeps into lungs, placentas, bloodstreams—and, confirmed now, brains.
Who profits from the microbial promise
Biotech firms rush to patent new hydrolases or “super-charged” microbial strains (Kawai et al., 2020). Rather than preventing pollution, they see a revenue stream in “recycling services.” Meanwhile, wealthy nations continue generating plastic mountains, believing they can pay for “cleanup” via engineered enzymes, while poorer communities, already inundated with waste exports, remain locked out of proprietary technologies.
If lawmakers believe a microbial fix is imminent, they’ll let petrochemical giants keep pumping out polymers. This ensures corporate profit while health and environmental costs escalate, hitting marginalized populations the hardest.
Engineered microbes that readily chew through PET or other plastics could also target essential infrastructure. A rogue, high-efficiency “plastivore” might devastate medical devices, water systems, or electronics (Mohanan et al., 2020). The line between “green solution” and biosecurity threat grows razor-thin when plastic underpins so many critical technologies.
Shut off the plastic tap
Microplastics provoke inflammation and oxidative stress; nanoplastics entered human liver and lung cells and damaged their mitochondria (Lin et al., 2022). If these particles act the same way in neural tissue, they could trigger glial hyperactivation, harm neurons, and alter brain function.
Do we really need more data to acknowledge that plastic in our gray matter is unacceptable?
Outlaw single-use packaging, microbeads, and polystyrene foam. Forcing industry to adapt now spurs real innovation in sustainable materials, not just talk of “enzymatic miracles.” Mega-producers must pay for the damage they cause through taxes on virgin polymer and strict liability for health and environmental harm. If they can’t profit from infinite waste, they’ll finally reduce production.
All microbial or enzymatic “solutions” must operate under rigorous containment and transparent governance. Patenting “cleanup microbes” to safeguard corporate bottom lines is unconscionable. If pursued at all, such research belongs in the public domain for the public good.
Cities and consumers are already fighting back. Local bans on single-use plastics, deposit-refund systems, and zero-waste movements show that immediate, tangible actions are possible. Every city that outlaws polystyrene or plastic bags chips away at the myth that we need plastic for daily life.
With microplastics crossing into the human brain, the crisis can’t be dismissed as “marine litter.” Reject the plastobiome delusion.
Enzymes that degrade PET in a lab? Intriguing science, but nowhere near the silver bullet corporate PR suggests. Plastic flooding our planet has already penetrated our vital organs, including our brains.
Until production falls, the concentrations in our brains will keep rising, whatever the microbial promises say.
References
- Yoshida, S. et al. (2016). A bacterium that degrades and assimilates poly(ethylene terephthalate). Science, 351(6278), 1196–1199.
- Taniguchi, I. et al. (2019). Biodegradation of PET: current status and application aspects. ACS Catalysis, 9(5), 4089–4105.
- Knott, B. C. et al. (2020). Characterization and engineering of a two-enzyme system for plastics depolymerization. Proceedings of the National Academy of Sciences, 117(41), 25476–25485.
- Palm, G. J. et al. (2019). Structure of the plastic-degrading Ideonella sakaiensis MHETase bound to a substrate. Nature Communications, 10(1), 1717.
- Tournier, V. et al. (2023). Enzymes’ power for plastics degradation. Chemical Reviews, 123(9), 5612–5701.
- Kawai, F., Kawabata, T., & Oda, M. (2020). Current state and perspectives related to the polyethylene terephthalate hydrolases available for biorecycling. ACS Sustainable Chemistry & Engineering, 8(24), 8894–8908.
- Wei, R., & Zimmermann, W. (2017). Biocatalysis as a green route for recycling the recalcitrant plastic polyethylene terephthalate. Microbial Biotechnology, 10(6), 1302–1307.
- Lin, S., Zhang, H., Wang, C., et al. (2022). Metabolomics reveal nanoplastic-induced mitochondrial damage in human liver and lung cells. Environmental Science & Technology, 56(17), 12483–12493.
- Margulis, L. (1981). Symbiosis in cell evolution. W.H. Freeman.
- Mohanan, N., Montazer, Z., Sharma, P. K., & Levin, D. B. (2020). Microbial and enzymatic degradation of synthetic plastics. Frontiers in Microbiology, 11, 580709.
- Nihart, A. J., Garcia, M. A., El Hayek, E., et al. (2025). Bioaccumulation of microplastics in decedent human brains. Nature Medicine. https://doi.org/10.1038/s41591-024-03453-1
- Kopatz, V., Wen, K., Kovács, T., et al. (2023). Micro- and nanoplastics breach the blood–brain barrier (BBB): Biomolecular corona’s role revealed. Nanomaterials, 13(8), 1404. https://doi.org/10.3390/nano13081404